These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8932068)

  • 1. Recombinant tissue plasminogen activator.
    Bell SG
    Neonatal Netw; 1996 Sep; 15(6):13-8. PubMed ID: 8932068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin.
    Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L
    Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of tissue type plasminogen activator in neonates: case reports and review of the literature.
    Smets K; Vanhaesebrouck P; Voet D; Schelstraete P; Govaert P
    Am J Perinatol; 1996 May; 13(4):217-22. PubMed ID: 8724722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of 40 kHz ultrasound on tissue plasminogen activator-induced clot lysis in three in vitro models.
    Pieters M; Hekkenberg RT; Barrett-Bergshoeff M; Rijken DC
    Ultrasound Med Biol; 2004 Nov; 30(11):1545-52. PubMed ID: 15588966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis for intravascular thrombosis in neonates and children.
    Raffini L
    Curr Opin Pediatr; 2009 Feb; 21(1):9-14. PubMed ID: 19242237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination thrombolytic and anticoagulant therapy for bilateral renal vein thrombosis in a premature infant.
    Weinschenk N; Pelidis M; Fiascone J
    Am J Perinatol; 2001 Aug; 18(5):293-7. PubMed ID: 11552182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant tissue-plasminogen activator for aortic thrombolysis in a hypoproteinemic dog.
    Clare AC; Kraje BJ
    J Am Vet Med Assoc; 1998 Feb; 212(4):539-43. PubMed ID: 9491162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant tissue plasminogen activator for central venous access device occlusion.
    Hooke C
    J Pediatr Oncol Nurs; 2000 Jul; 17(3):174-8. PubMed ID: 10944865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local thrombolysis with recombinant tissue plasminogen activator for thrombosed vascular access in hemodialysis patients.
    Vlassopoulos D; Logothetis E; Arvanitis D; Noussias C; Magana P; Katopodis K; Hadjiconstantinou V
    Clin Nephrol; 1996 Jul; 46(1):77-8. PubMed ID: 8832159
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children.
    Jacobs BR; Haygood M; Hingl J
    J Pediatr; 2001 Oct; 139(4):593-6. PubMed ID: 11598611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of the fibrinolytic system in the newborn].
    Schlegel N; Hurtaud-Roux MF; Beaufils F
    Ann Pediatr (Paris); 1993 Feb; 40(2):70-4. PubMed ID: 8457135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis in newborns and infants.
    Nowak-Göttl U; Auberger K; Halimeh S; Junker R; Klinge J; Kreuz WD; Ries M; Schlegel N
    Thromb Haemost; 1999 Sep; 82 Suppl 1():112-6. PubMed ID: 10695499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of local instillation of recombinant tissue plasminogen activator for restoring occluded central venous catheters in neonates.
    Soylu H; Brandão LR; Lee KS
    J Pediatr; 2010 Feb; 156(2):197-201.e1. PubMed ID: 19969306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability and sterility of recombinant tissue plasminogen activator at -30 degrees C.
    Wiernikowski JT; Crowther M; Clase CM; Ingram A; Andrew M; Chan AK
    Lancet; 2000 Jun; 355(9222):2221-2. PubMed ID: 10881901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remaining perspectives of mutant and chimeric plasminogen activators.
    Lijnen HR; Collen D
    Ann N Y Acad Sci; 1992 Dec; 667():357-64. PubMed ID: 1309056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
    Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful use of recombinant tissue plasminogen activator in the treatment of aortic thrombosis in a premature neonate.
    Torkington J; Hitchcock R; Wilkinson K; Kiely E
    Eur J Vasc Endovasc Surg; 1997 May; 13(5):515-6. PubMed ID: 9166277
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombus in right atrium in two infants successfully treated with tissue plasminogen activator.
    Martínez-Tallo E; Campo F; Delgado M; Marfíl S; Agulla E
    Pediatr Emerg Care; 1997 Feb; 13(1):37-9. PubMed ID: 9061735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of tissue plasminogen activator for thrombolysis in occluded peritoneal dialysis catheters in children.
    Shea M; Hmiel SP; Beck AM
    Adv Perit Dial; 2001; 17():249-52. PubMed ID: 11510286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.